DeepSeek V4 Pro 0813vsLaguna S 2.1 (free)

3-Month Longevity & Performance Plan for a Biohacker Disclaimer: This plan is for educational purposes only and is not medical advice. It assumes you are a healthy, active adult with no contraindications. Some components—especially prescription drugs, fasting, and high-intensity training—require medical supervision.

Comprehensive 3-Month Longevity Optimization Plan Phase 1: Foundation & Assessment (Month 1) Week 1-2: Baseline Establishment Comprehensive Health Testing Complete blood panel (CBC, CMP, lipid panel, inflammatory markers: hs-CRP, IL-6) Hormone panel (testosterone, estrogen, DHEA, cortisol, thyroid panel) Genetic…

This contract is heavily one-sided. Several clauses could be exploited against the contractor. Below is a clause-by-clause analysis, with proposed language changes and the legal reasoning behind each. Disclaimer: This is not legal advice. You should have a qualified contract attorney review any final agreement.

I'll analyze each clause for potential exploitation against the contractor and suggest improvements. Exploitable Clauses & Recommended Modifications SCOPE CLAUSE Problem: "Client reserves the right to modify the scope at any time without additional compensation" Allows unlimited scope creep without extra pay No…

IC Memo: LedgerLift (LLLT) Recommendation: Short 12-month PT range: $25–$31 (probability-weighted DCF ~$29) Thesis: LLLT is a high-quality SaaS compounder, but at $46 the market is pricing roughly 6.5% terminal growth or ~6.3% WACC in our base model, leaving no margin for error.

INTERNAL INVESTMENT COMMITTEE MEMO 1. Recommendation & Thesis Recommendation: LONG 12-Month Price Target Range: $62 – $75/share Thesis: LedgerLift is a high-quality B2B SaaS platform with strong recurring revenue, exceptional unit economics, and durable customer retention.